The impact of new medicines development on pharmaceutical analysis
Wiblin, C.N.; Hambleton, P.; Melling, J.; Scawen, M.
Journal of Pharmacy and Pharmacology 45(Suppl 1): 374-380
1993
ISSN/ISBN: 0022-3573 PMID: 8098746 Document Number: 417433
Document emailed within 1 workday
Related Documents
Brain, K.R. 1993: The implications of developments in pharmaceutical analysis and new medicines on pharmaceutical education Journal of Pharmacy and Pharmacology 45(Suppl 1): 381-383Coghlan, R.; Stephens, P.; Mwale, B.; Siyanga, M. 2018: A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia Malaria Journal 17(1): 444
Orubu, E.Samuel.F.; Okwelogu, C.; Opanuga, O.; Nunn, T.; Tuleu, C. 2016: Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development Health Policy and Planning (): -
Pijpers, E.L.; Kreijkamp-Kaspers, S.; McGuire, T.M.; Deckx, L.; Brodribb, W.; van Driel, M.L. 2017: Women's questions about medicines in pregnancy - An analysis of calls to an Australian national medicines call centre Australian and New Zealand Journal of Obstetrics and Gynaecology 57(3): 334-341
Berridge, J.C. 1993: Pharmaceutical analysis in a multidisciplinary development environment Journal of Pharmacy and Pharmacology 45(Suppl 1): 361-366
Parnovskiĭ, B.L. 1975: Informational approach to the analysis of the development of pharmaceutical science Farmatsevtychnyi Zhurnal 1: 86-89
McKay, B.; Hoogenraad, M.; Damen, E.W.; Smith, A.A. 2003: Advances in multivariate analysis in pharmaceutical process development Current Opinion in Drug Discovery and Development 6(6): 966-977
Friedrich, C.; Langer, H.; Seidlein, H.J.; von Weigel, C.E. 1982: History of pharmaceutical science. 3. Christian Ehrenfried von Weigel--his importance in the development of pharmaceutical science? 1: his origins and development Die Pharmazie 37(4): 290-293
Davidová, J.; Ivanovic, N.; Práznovcová, L. 2008: Participation in pharmaceutical costs and seniors' access to medicines in the Czech Republic Central European Journal of Public Health 16(1): 26-28
Burroughs, V.J.; Maxey, R.W.; Levy, R.A. 2002: Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment Journal of the National Medical Association 94(10 Suppl): 1-26
Wang, H.; Zhang, X-Bo.; Huang, L-Qi.; Guo, L-Ping.; Wang, L.; Zhao, Y-Ping.; Yang, G. 2017: Design and implementation of supply security monitoring and analysis system for Chinese patent medicines supply in national essential medicines Zhongguo Zhong Yao Za Zhi 42(22): 4310-4313
Cottingham, J.; Berer, M. 2011: Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation Reproductive Health Matters 19(38): 69-84
Hermanowski, T.; Bystrov, V.; Staszewska-Bystrova, A.; Szafraniec-Buryło, S.I.; Rabczenko, D.; Kolasa, K.; Orlewska, E. 2015: Analysis of Trends in Life Expectancies and per Capita Gross Domestic Product as well as Pharmaceutical and Non-Pharmaceutical Healthcare Expenditures Acta Poloniae Pharmaceutica 72(5): 1045-1050
Amin, A.S. 2001: Pyrocatechol violet in pharmaceutical analysis. Part I. A spectrophotometric method for the determination of some beta-lactam antibiotics in pure and in pharmaceutical dosage forms Farmaco 56(3): 211-218
Robinson, W.C.; Kantner, J.F. 1988: The impact of development programmes on fertility: a framework for analysis Asia-Pacific Population Journal 3(3): 65-80
Robinson, W.C.; Kantner, J.F. 1988: The impact of development programmes on fertility: a framework for analysis Asia-Pacific Population Journal 3(3): 65-80
Chaurasia, A.R. 2004: Fertility in the development blocks of Madhya Pradesh : An analysis of the impact of contraceptive use Social Change 34(2): 26-39
Yang, H.; Xiao, F.; Yin, D.; Li, R.; Xin, Q.; Zheng, X.; Yin, T.; Wang, L.; Cui, M.; Xu, Q.; Chen, B. 2014: Impact analysis on the health management programs among community-based 0-36-month-olds on their growth and development Zhonghua Liu Xing Bing Xue Za Zhi 35(11): 1244-1248
Thompson, R.S. 1998: Impact of patient-directed pharmaceutical advertising American Family Physician 57(7): 1499
Bador, P.; Grand, C.; Locher, F. 1996: French language pharmaceutical publications in 1995. I. Assessment and analysis of French language pharmaceutical periodicals Journal de Pharmacie de Belgique 51(2): 74-81